电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

MERS-CoV 抗体

(MERS-Coronavirus (MERS-CoV))

7 results

MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, WB 宿主: 小鼠 Monoclonal AT2F7 unconjugated Recombinant Antibody
产品编号 ABIN7573664
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, Neut 宿主: Human Monoclonal CDC2-C2 unconjugated Recombinant Antibody
产品编号 ABIN7573666
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, Neut 宿主: Human Monoclonal JC57-14 unconjugated Recombinant Antibody
产品编号 ABIN7573665
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, Neut 宿主: Human Monoclonal MCA1 unconjugated Recombinant Antibody
产品编号 ABIN7573667
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Neut, SPR, FACS 宿主: Human Monoclonal 4V2 unconjugated Recombinant Antibody
产品编号 ABIN7573669
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, SPR 宿主: Human Monoclonal LCA60 unconjugated Recombinant Antibody
产品编号 ABIN7573668
 
MERS-CoV 适用: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, IF 宿主: 小鼠 Monoclonal 3871 unconjugated
产品编号 ABIN6952845
 
  • 类型 Primary
    • Primary
  • 应用范围
    • ELISA
    • Neutralization (Neut)
    • Surface Plasmon Resonance (SPR)
    • Flow Cytometry (FACS)
    • Immunofluorescence (IF)
    • Western Blotting (WB)
  • 适用
    • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  • 抗体来源
    • Human
    • Mouse
  • 克隆形成能力
    • Monoclonal
  • 克隆
    • 3871
    • 4V2
    • AT2F7
    • CDC2-C2
    • JC57-14
    • LCA60
    • MCA1
  • 抗原表位
    • RBD
  • 标记
    • 非结合性
  • 抗体亚型
    • IgG1
    • IgG2a
    • kappa
  • 蛋白类型
    • Recombinant Antibody
  • Format
    • Liquid
  • Supplier
    • antibodies-online
    • ProSci

Latest Publications for our MERS-CoV 抗体

Folegatti, Bittaye, Flaxman, Lopez, Bellamy, Kupke, Mair, Makinson, Sheridan, Rohde, Halwe, Jeong, Park, Kim, Song, Boyd, Tran, Silman, Poulton, Datoo, Marshal, Themistocleous, Lawrie, Roberts et al.: "Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. ..." in: The Lancet. Infectious diseases, (2020) (PubMed).

Langenmayer, Lülf-Averhoff, Adam-Neumair, Fux, Sutter, Volz: "Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 54, pp. 58-62, (2018) (PubMed).

Zhao, Zhou, Zhang, Chu, Liu, Poon, Chan, Leung, Fai, Lin, Zhang, Jin, Yuen, Zheng: "A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses." in: Scientific reports, Vol. 6, pp. 22008, (2016) (PubMed).

Hart, Dyall, Postnikova, Zhou, Kindrachuk, Johnson, Olinger, Frieman, Holbrook, Jahrling, Hensley: "Interferon-? and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays." in: The Journal of general virology, Vol. 95, Issue Pt 3, pp. 571-7, (2014) (PubMed).

Dyall, Coleman, Hart, Venkataraman, Holbrook, Kindrachuk, Johnson, Olinger, Jahrling, Laidlaw, Johansen, Lear-Rooney, Glass, Hensley, Frieman: "Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection." in: Antimicrobial agents and chemotherapy, Vol. 58, Issue 8, pp. 4885-93, (2014) (PubMed).

You are here:
Chat with us!